Literature DB >> 21324544

Participation bias in a randomised trial of screening for lung cancer.

Mie Sara Hestbech1, Volkert Siersma, Asger Dirksen, Jesper H Pedersen, John Brodersen.   

Abstract

INTRODUCTION: Participation bias might affect the results and the representability of randomised controlled trials. We investigated the degree of socio-demographic and psychosocial participation bias in the Danish Lung Cancer Screening Trial (DLCST).
METHODS: In DLCST the questionnaire COS-LC (Consequences of Screening in Lung Cancer) was used to measure the psychosocial aspects of screening. To investigate a difference with a comparable representative sample from the Danish population, we sent out an inclusion questionnaire to 3999 Danes in the age from 50 to 70 years randomly selected from the Central National Register. Those who completed the inclusion questionnaire and met the inclusion criteria from DLCST received the COS-LC. Those who completed the COS-LC-and thus formed a population sample comparable to DLCST - were compared to the DLCST participants on socio-demographics and psychosocial measures.
RESULTS: Participation rates were high among the comparable population sample: 75.3% completed the inclusion questionnaire and 77.4% of those who were eligible completed the COS-LC. The analyses revealed differences between the DLCST participants and the comparable population sample in the following socio-demographic aspects: social group, living alone, gender, age and geographical area. DLCST participants reported less negative psychosocial aspects than the comparable population sample.
CONCLUSION: The present study has shown substantial socio-demographic and psychosocial participation bias in DLCST.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21324544     DOI: 10.1016/j.lungcan.2010.12.018

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  30 in total

Review 1.  Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps.

Authors:  Emma Louise O'Dowd; David R Baldwin
Journal:  Br J Radiol       Date:  2017-10-17       Impact factor: 3.039

Review 2.  Smoking cessation and lung cancer screening.

Authors:  Jesper Holst Pedersen; Philip Tønnesen; Haseem Ashraf
Journal:  Ann Transl Med       Date:  2016-04

Review 3.  The importance of incorporating smoking cessation into lung cancer screening.

Authors:  Jennifer Anne Minnix; Maher Karam-Hage; Janice A Blalock; Paul M Cinciripini
Journal:  Transl Lung Cancer Res       Date:  2018-06

4.  Distress and patient-centered communication among veterans with incidental (not screen-detected) pulmonary nodules. A cohort study.

Authors:  Christopher G Slatore; Sara E Golden; Linda Ganzini; Renda Soylemez Wiener; David H Au
Journal:  Ann Am Thorac Soc       Date:  2015-02

5.  Generalizability and reach of a randomized controlled trial to improve oral health among home care recipients: comparing participants and nonparticipants at baseline and during follow-up.

Authors:  Jonas Czwikla; Alexandra Herzberg; Sonja Kapp; Stephan Kloep; Heinz Rothgang; Ina Nitschke; Cornelius Haffner; Falk Hoffmann
Journal:  Trials       Date:  2022-07-08       Impact factor: 2.728

Review 6.  Psychological Burden Associated With Lung Cancer Screening: A Systematic Review.

Authors:  Geena X Wu; Dan J Raz; Laura Brown; Virginia Sun
Journal:  Clin Lung Cancer       Date:  2016-03-30       Impact factor: 4.785

7.  Neighborhood Disadvantage and Lung Cancer Incidence in Ever-Smokers at a Safety Net Health-Care System: A Retrospective Study.

Authors:  Yosra Adie; Daniel J Kats; Abdulhakim Tlimat; Adam Perzynski; Jarrod Dalton; Douglas Gunzler; Yasir Tarabichi
Journal:  Chest       Date:  2019-12-17       Impact factor: 9.410

8.  CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication.

Authors:  Linda Kaerlev; Maria Iachina; Jesper Holst Pedersen; Anders Green; Bente Mertz Nørgård
Journal:  BMC Cancer       Date:  2012-05-23       Impact factor: 4.430

9.  Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial.

Authors:  Louise Mosborg Aggestrup; Mie Sara Hestbech; Volkert Siersma; Jesper Holst Pedersen; John Brodersen
Journal:  BMJ Open       Date:  2012-03-01       Impact factor: 2.692

Review 10.  Patient-centered outcomes among lung cancer screening recipients with computed tomography: a systematic review.

Authors:  Christopher G Slatore; Donald R Sullivan; Miranda Pappas; Linda L Humphrey
Journal:  J Thorac Oncol       Date:  2014-07       Impact factor: 20.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.